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Little is known regarding the potential risk posed by aerosolized prions. Chronic wasting disease
(CWD) is transmitted horizontally, almost surely by mucosal exposure, and CWD prions are
present in saliva and urine of infected animals. However, whether CWD may be transmissible by
the aerosol or nasal route is not known. To address this question, FVB mice transgenetically
expressing the normal cervid PrP
C protein [Tg(cerPrP) mice] were exposed to CWD prions by
either nose-only aerosol exposure or by drop-wise instillation into the nostrils. Mice were
monitored for signs of disease for up to 755 days post-inoculation (p.i.) and by examination of
tissues for lesions and PrP
CWD after necropsy. In particular, nasal mucosa, vomeronasal organ,
lungs, lymphoid tissue and the brain were assessed for PrP
CWD by Western blotting and
immunohistochemistry. Six of seven aerosol-exposed Tg(cerPrP) mice developed clinical signs of
neurological dysfunction mandating euthanasia between 411 and 749 days p.i. In all these mice,
CWD infection was confirmed by detection of spongiform lesions and PrP
CWD in the brain. Two of
nine intranasally inoculated Tg(cerPrP) mice also developed transmissible spongiform
encephalopathy associated with PrP
CWD between 417 and 755 days p.i. No evidence of PrP
CWD
was detected in CWD-inoculated Tg(cerPrP) mice examined at pre-terminal time points. These
results demonstrate that CWD can be transmitted by aerosol (as well as nasal) exposure and
suggest that exposure via the respiratory system merits consideration for prion disease
transmission and biosafety.
INTRODUCTION
Chronic wasting disease (CWD) is an efficiently transmit-
ted prion disease [transmissible spongiform encephal-
opathy (TSE)] affecting deer, elk and moose. Although
discovered in Northern Colorado and Southern Wyoming,
CWD has since been identified in 13 additional states,
three Canadian providences and Korea (Dube et al., 2006;
http://wildlifedisease.nbii.gov/documents/update%2094.pdf,
2009; Kim et al., 2005). CWD is unique as the only TSE that
occurs in wild animal populations.
Available information indicates that CWD is transmitted
by some horizontal means, most likely involving trans-
mucosal entry (Miller & Williams, 2003; Sigurdson et al.,
1999; Williams, 2005). CWD prions are known to be
present in saliva and urine of infected cervids (Haley et al.,
2009; Mathiason et al., 2006) and excreted prions can
contaminate the environment and persist for years, given
that clay components of soil bind prion proteins with
high affinity (Johnson et al., 2006). Exposure of the nasal
or other respiratory mucosa via aerosolization or direct
contact to CWD prions is sufficient to initiate infection
and disease remains unproven, yet plausible. Precedent for
nasal transmission of prion disease can be found in studies
of experimental scrapie in sheep and mice and transmiss-
ible mink encephalopathy (TME) in hamsters (Hamir
et al., 2008; Kincaid & Bartz, 2007; Sbriccoli et al., 2008).
Olfactory sensory nerve endings in the olfactory epithelium
(Buck & Axel, 1991) of animals such as cervids are highly
developed to monitor the environment, e.g. to locate food,
predators and prey, and detect the pheromones initiating
reproductive behaviours (Dulac, 2000; Thorne & Amrein,
2003). Reproductive cues in particular are detected by the
Flehmen response that draws the trapped particulates into
the vomeronasal organ (VNO), a specialized neurosensory
region in the anterior nasal mucosa (Doving & Trotier,
1998). The Flehmen response and social nuzzling both
provide opportunities for CWD prions to enter the nasal
passages.
To determine directly whether CWD is transmissible by the
respiratory route, cervid PrP-expressing transgenic mice
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All IC-inoculated mice exhibited clinical symptoms of
CWD at 168±4 days post-inoculation (p.i.) and were
euthanized. PrP
CWD was detected in all positive controls by
Western blot (WB) and immunohistochemistry (IHC),
thus confirming the infectivity of the inoculum (data not
shown).
Aerosol exposure
In our first aerosol exposure of Tg(cerPrP) mice, four of six
CWD and three of six sham-exposed mice died within 0–
6 days p.i. The cause of death was not determined with
certainty. After modification to the exposure protocol no
similar fatalities occurred. Of a total of the seven mice
exposed to CWD by aerosol, six developed TSE between
411 and 749 days p.i. None of the sham-inoculated mice
developed evidence of prion infection through 749 days
p.i. of observation. Neurological signs, survival times,
weight loss and development of TSE lesions (primarily
neuronal loss/vacuolation and gliosis) within the brain for
the aerosol-exposed mice are summarized in Table 1 and
Fig. 1(a).
WB and IHC analysis of brains from the seven CWD-
aerosol-exposed mice demonstrated PrP
CWD in six of them
(Figs 2a and 3a). All of the mice exposed by aerosol to
CWD-negative control deer brain inoculum were negative
for PrP
CWD by WB (Fig. 2a, lanes 1 and 2) and IHC
(Fig. 3b). IHC of the nasal passages, including the VNO,
olfactory and respiratory epithelium, and nasal-associated
lymphoid tissue (NALT), as well as the olfactory bulb of




Nine of 12 Tg(cerPrP) mice exposed to CWD by IN
inoculation survived past 250 days p.i. Two of these nine
mice developed TSE at 422 and 498 days p.i., respectively.
A summary of neurological signs, survival times, weight
loss and development of TSE lesions (primarily neuronal
loss/vacuolation and gliosis) is in Table 2 and Fig. 1(b).
Both IN-inoculated mice that developed TSE had PrP
CWD
accumulation in the brain, as detected by WB (Fig. 2b,
lanes 4 and 6) and IHC (Fig. 3c). None of the mice
exposed intranasally to CWD-negative control deer brain
inoculum displayed clinical signs of CWD. All were
negative for PrP
CWD by WB (Fig. 2b, lanes 1 and 2) and
Table 1. Aerosol transmission of CWD in Tg(cerPrP) mice
+, Present; 2 not present.
Animal no. Neurological signs* Survival (days p.i.) Weight loss
(% max. body wt)
PrP
CWD WB PrP
CWD IHC TSE lesions
Sham n55 2 411–749 2 (average) 22 2
384 + 411 31 ++ +
746 + 417 32 ++ +
739 + 457 35 22 2
732 + 524 27 ++ +
734 + 563 31 ++ +
738 2 708 11 2 + 2
380 + 749 12 ++ +
*Animals were considered positive if they exhibited at least three of the following symptoms: ataxia, lethargy, tremors, weight loss, poor coat quality
or rigid tail.
Fig. 1. Kaplan–Meier survival plot of Tg(CerPrP) mice exposed to
CWD by aerosol (#, black dotted line) versus IN instillation ($,
black solid line).
N. D. Denkers and others
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inoculated mice sacrificed at planned time points or dying
spontaneously was evidence of PrP
CWD or histopathologic
lesions of TSE detected (data not shown). PrP
CWD was also
not detected in the nasal passages, olfactory bulb or spleen
of any mice (data not shown).
Statistical analysis
Using the Fisher’s exact test, the attack rates in Tg(CerPrP)
mice exposed to CWD by aerosol versus nasal inoculation
were demonstrated as being significantly different (Fisher’s
exact test, P-value50.0406).
Dose estimations
To estimate the quantity of brain material delivered per
mouse by aerosol exposure, we used lognormal distri-
bution generator assumptions and calculations as described
in Methods. Based on particle sizes ranging from 0.1 to
10 mm (log distribution) generated by the nebulizer, we
estimated that 24 mg of solid brain material was deposited
on the mucous membranes of each mouse. Applying the
same algorithm to IN exposure produces an estimated
value of 100 mg of brain material delivered per mouse.
DISCUSSION
In 1995, Shaw (1995) suggested that the occurrence of a
shorter incubation period for Creutzfeldt–Jakob disease
(CJD) in farmers could have come from ‘breathing the dust
from feed containing prion’. The present studies were done
to simulate the inhalation of airborne particles and the
direct contamination of the nasal passages with CWD
(a)
(b)
Fig. 2. (a) PrP
CWD (lanes 3, 4, 6, 7 and 9) in brains of Tg(CerPrP)
mice exposed to aerosolized CWD prions demonstrated by WB.
Aerosolized sham control (lanes 1 and 2) showing no PrP
CWD. (b)
PrP
CWD (lanes 4 and 6) in brains of Tg(CerPrP) mice exposed to
CWD prions intranasally demonstrated by WB. Intranasal sham




Fig. 3. IHC from the obex region of the
medulla from Tg(CerPrP) mice (20 mag-
nification). (a) PrP
CWD (arrows) in a mouse
exposed to CWD by aerosol versus (b) mouse
exposed to sham inoculum. (c) Mouse exposed
to CWD by IN route demonstrating PrP
CWD
aggregates (arrows) versus (d) mouse
exposed intranasally to sham inoculum.
Aerosol transmission of CWD
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via inhalation (perhaps even more effectively than by
nostril contact only), while unique for CWD infection,
extends precedent for transmission of prions via the
respiratory system. Sheep and hamsters inoculated with
scrapie intranasally (Hamir et al., 2008; Sbriccoli et al.,
2008) and hamsters inoculated with TME extranasally
(Kincaid & Bartz, 2007) have been shown to develop TSE.
Results in the latter study suggested that the nasal passages
may even be more effective than the oral route in
transmitting prion disease (Kincaid & Bartz, 2007).
In the present study, 86% (six of seven) of Tg(cerPrP)
mice exposed to CWD via aerosol developed CWD versus
22% (two of nine) of IN-exposed mice (Fisher’s exact test,
P-value50.0406). It may be argued that the early deaths
of four mice in the initial CWD-aerosol exposure group
could bias the statistical significance of the results. After
modifications to the exposure procedure, early mortalities
were eliminated. Moreover, two of two surviving mice in
the initial exposure and four of five mice in the second
exposure study developed TSE.
One possible explanation for the enhanced infectivity after
aerosol exposure might be the disruption and dispersion of
infectious PrP
CWD aggregates during aerosolization to yield
more small infectious particles or seeds (Silveira et al.,
2005). These smaller aggregates might be more readily
taken up by lymphoid or distal airway epithelial cells not
typically accessible by either nasal contact or drop-wise
instillation of prions.
Another potential explanation for enhanced infection after
aerosolization could be that a larger prion dosage was
delivered by aerosol versus nasal exposure. Based on a
random distribution of infectivity in the aerosol material,
the respiratory tidal volume of mice and the average
anaesthetized respiratory rate for a 4 min period, we cal-
culated that aerosol-exposed mice would receive approxi-
mately 1.2% of the available inoculum, or a maximum of
24 mg of particulate inoculum deposited in the respiratory
system. Mice inoculated intranasally received 10 mlo fa
10% brain homogenate or 100 mg of particulate inoculum
– four times that delivered by aerosol. Given that only the
nostril region (,5 mm) of each mouse was exposed during
aerosolization, we estimate that even if up to an additional
15 ml of inoculum were to be ingested due to nasal region
grooming, the total dosage would not surpass (and more
likely would never attain) that delivered intranasally.
Clearly, inoculation by either the aerosol or nasal route
would result in inoculum entering the alimentary tract via
the nasopharynx. Thus, oral exposure and potential uptake
cannot be avoided or excluded. However, oral inocula-
tion of Tg(cerPrP) mice with 100 mg CWD particulate
brain homogenate failed to transmit CWD infection or
disease after .700 days of observation (D. M. Seelig, G. L.
Mason, G. C. Telling & E. A. Hoover, unpublished results)
(Table 3). Thus, it is unlikely that CWD transmission
by the aerosol or nasal routes reflects infection via the
alimentary tract.
Table 2. IN transmission of CWD in Tg(cerPrP) mice
+, Present; 2 not present.
Animal no. Neurological signs* Survival (days p.i.) Weight loss
(% max. body wt)
PrP
CWD WB PrP
CWD IHC TSE lesions
Sham n59 2 361–755 5 (average) 22 2
635 + 361 39 22 2
641 + 422 43 ++ +
646 + 443 50 22 2
631 + 498 17 ++ +
633 2 551 +14 22 2
630 2 755 23 22 2
632 2 755 15 22 2
645 2 755 19 22 2
648 2 755 35 22 2
*Animals were considered positive if they exhibited at least three of the following symptoms: ataxia, lethargy, tremors, weight loss, poor coat quality
or rigid tail.
Table 3. Summary of CWD inoculation results in Tg(cerPrP)
mice
Route Exposure dose Attack rate*
Aerosol 24 mgD 6/7 (86%)
IN 100 mgd 2/9 (22%)
Oral 100 mg§ 0/10 (0%)
*No. affected/no. total (% positive).
D4 min aerosol of 5% (w/v) homogenate.
d10 ml of 10% (w/v) homogenate.
§100 ml of 1% (w/v) homogenate.
N. D. Denkers and others
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direct nasal contact transmissions because they are obligate
nasal breathers (Klemens et al., 2005). Odorants and
particles inhaled into the nasal passage are subject to a
number of cell surfaces. Thus, multiple sites of CWD prion
entry are plausible, including the NALT, the mucosal
associated macrophages and/or dendritic cells, respiratory
epithelium, olfactory epithelium and VNO. The NALT
typically incorporates the retropharyngeal lymph nodes,
palatine and lingual tonsil (Kuper et al., 1992) and is
similar in structure and function to the gut-associated
lymphoid tissue (GALT) in that it is responsible for antigen
uptake and presentation by M cells, B cells and follicular
dentritic cells (Heritage et al., 1997; Kuper et al., 1992). The
GALT, especially the Peyer’s patches, is considered to be
the primary site of PrP
Sc uptake for BSE, variant CJD and
scrapie (Beekes & McBride, 2000; Fox et al., 2006; Heggebo
et al., 2002; Press et al., 2004; Spraker et al., 2002b; van
Keulen et al., 2008).
Mice do not have tonsils or retropharyngeal lymph nodes
per se, but rather a bi-symmetrical NALT structure that
lines the floor of the nasal cavity (Heritage et al., 1997).
Kincaid & Bartz (2007) found that hamsters inoculated
via uptake of droplets of TME inoculum via the external
nares had shorter incubation periods using a lower dose
of infectious prions than those inoculated orally. Studies
in deer inoculated orally or naturally exposed to CWD
indicate that the primary structures that accumulate
PrP
CWD early in infection are the retropharyngeal lymph
nodes and tonsils (Keane et al., 2008; Sigurdson et al., 1999;
Spraker et al., 2004). Nevertheless, in the present study we
were unable to demonstrate PrP
CWD in the NALT of early,
pre-terminal or terminal Tg(cerPrP) mice after aerosol or
nasal exposure to CWD.
Another seemingly probably site for prion entry and
infection is the olfactory mucosal epithelium, which
contains odour receptors that provide a direct neural
connection from the nasal cavity to the olfactory bulbs of
the brain. Previous IHC studies of deer terminally infected
with CWD have demonstrated PrP
CWD depositions in the
olfactory bulbs, which also show marked spongiform
degenerative changes (Spraker et al., 1997, 2002b;
Williams & Young, 1992, 1993). However, in deer,
sequential PrP
CWD accumulation in the brain appears to
occur in a caudal (brainstem) to rostral (frontal cortex)
fashion as the disease progresses (Spraker et al., 2002a). In
the present study, PrP
CWD was not detected in the olfactory
bulbs of terminal CWD-infected Tg(cerPrP) mice,
although aggregates were identified in the frontal cortex
immediately dorsal to the olfactory bulbs in some mice.
This was especially surprising since the olfactory bulb
glomeruli are sites of substantial cervid PrP
C expression in
naı ¨ve Tg(cerPrP) mice.
Given that CWD prions have been demonstrated in saliva
(Mathiason et al., 2006), urine (Haley et al., 2009; Kariv-
Inbal et al., 2006) and soil (Johnson et al., 2006), it is
possible that prion entry could involve the VNO – a region
of the anterior ventral nasal passages specialized to detect
non-volatile molecules such as pheromones by a process
known as the Flehmen response (Thorne & Amrein, 2003;
Kelliher et al., 2001; Meredith & O’Connell, 1979).
Nevertheless, neither we nor DeJoia et al. (2006) were able
to detect PrP
RES in the VNO of terminal CWD-inoculated
Tg(cerPrP) mice or TME-inoculated hamsters, respect-
ively. Thus, while all of the above exposure studies failed to
identify PrP
CWD/RES in mucosal sites, it remains likely that
early prion trafficking involves relatively few potential
protease-sensitive oligomeric molecules, which may not be
identifiable with the detection methods used.
Our inability to detect PrP
CWD outside the central nervous
system in the present studies was somewhat perplexing.
This finding could reflect a more limited peripheral
expression of PrP
C expression in the Tg(cerPrP) mice
versus deer, although other studies in our laboratory have
demonstrated PrP
C in many peripheral tissues of
Tg(cerPrP) mice (D. M. Seelig, G. L. Mason, G. C.
Telling & E. A. Hoover, unpublished results). Addition-
ally, overfixation of our tissues could eliminate possible
PrP
CWD aggregates. An alternative explanation would be
that TSE induced by nasal exposure to CWD prions in
Tg(cerPrP) mice in mediated largely by non-lymphore-
ticular system pathways. Such a pathway is supported by
the recent work of Bessen et al. (2009), demonstrating that
IN inoculation of RML scrapie into immunodeficient
transgenic mice transmits TSE without lymphoreticular
system involvement.
In summary, the present study demonstrates the transmis-
sibility of prions via aerosolization. Several aspects of
respiratory transmission of CWD prions remain to be
refined and no evidence of a peripheral or lymphoid phase
of the infection was detected. The results suggest that prion
exposure via the respiratory system merits consideration in
prion transmission and biosafety.
METHODS
Tg(CerPrP) mice. The cervid PrP-expressing transgenic mice and
their susceptibility to CWD infection after IC inoculation have been
described previously (Browning et al., 2004). All mice were cared for
in accordance with the Colorado State University ACUC guidelines.
Confirmation of the cervid PrP
C gene insert was performed by WB
and PCR. The Tg(cerPrP) mice were five to 12 weeks of age at
inoculation. After inoculation, mice were examined for evidence of
neurological abnormality every 2 days, and weighed weekly (starting
at 3 months p.i.). Clinical criteria for assessing CWD symptoms
included ataxia, lethargy, tail rigidity, poor coat quality and weight
loss. Once the onset of clinical signs was observed, mice were isolated
into individual cages to prevent cannibalism from cage mates. Mice
were euthanized when distinct signs of neurological disease were
evident. CWD- and sham-inoculated mice were housed in separate
rooms to minimize the potential of cross contamination.
Inocula and inoculation routes. The CWD inoculum consisted of
brain homogenate from CWD-infected mule deer (D10), obtained
through the courtesy of Dr Michael Miller, Colorado Division of
Aerosol transmission of CWD
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from a CWD-naı ¨ve white-tailed deer brain (UGA) obtained through
the courtesy of Drs David Osborn, Carl Miller and Robert Warren at
the University of Georgia Warnell School of Forestry, USA. Brain
homogenates were prepared in 16 PBS to a final concentration of
10% (w/v) for IN, 5% (w/v) for aerosol and 1% for IC and per os
(PO) inoculations. All mice (except IC and PO) were administered
0.01 ml epinephrine intraperitoneally, immediately p.i. to stimulate
the Flehmen response.
In two separate experiments, two cohorts of Tg(CerPrP) mice (n56
CWD and n56 sham) were inoculated by exposure to an aerosol of
5% (w/v) CWD brain homogenate for 4 min in a custom designed
chamber providing nose-only exposure. The mice were monitored
until clinical symptoms were detected or until study termination at
749 days. Two additional cohorts of Tg(CerPrP) mice (n524 CWD
and n524 sham) were inoculated with 10 ml( 5ml per nostril) of the
10% weight to volume (w/v) extracts by direct pipette instillation
into the nasal passages. A total of 12 mice in each cohort (n54 per
time point) were sacrificed at 7, 14 and 28 days p.i. and analysed for
early PrP
CWD detection. The remaining mice (12 per cohort) were
monitored either until clinical symptoms became apparent or to
study termination at 755 days. Per os inoculations into Tg(CerPrP)
mice were administered in 2–50 ml doses of a 1% extract given on two
consecutive days. IC inoculations into Tg(CerPrP) mice of 30 mlo fa
1% extract from the same positive mule deer (D10) or naı ¨ve white-
tailed deer (UGA) served as positive and negative controls.
Aerosolizing chamber. Aerosolizing chambers commonly expose
the entire animal to the agent being investigated. Our goal was to
expose only the nose/nasal passages to CWD prions versus the entire
animal. Thus, we (N.D.D./J.H.K.) fashioned an exposure chamber
using a 473 ml, rubber-sealed lid container (Rubbermaid) into which
4–19 diameter holes were drilled into the side walls. Four, 50 ml
conical tubes (BD) with the tips removed were inserted and sealed
into the holes. Each tube was supported by an additional tube that
collectively functioned as legs. A 3/4961/29 hole was also cut into the
container to accommodate the mouth of the Omron Nebulizer
(Ultranebs). The conical tubes and the nebulizer were sealed in place
with silicone adhesive (GOOP). Finally, a 0.22 mm filter unit
(Sterivex; Millipore) was attached and sealed to the lid of the
container to serve as an air vent and trap aerosolized particles
(Fig. 4a). After the mice and the inocula had been loaded into the
apparatus (Fig. 4b), the entire chamber was placed in a secondary
enclosure and exposure occurred in a separately vented room.
Statistical analysis. Statistics (Fisher’s exact test) were performed
using the software package Graphpad Prism 4.
Delivered dose estimations. To approximate the total solid mass of
brain inoculum deposited onto the mucous membranes of each
aerosol-exposed mouse, we used a lognormal distribution generator
program created by Dr J. Volckens (Department of Environmental
and Radiological Health Sciences, Colorado State University, USA),
using modified equations (Hinds, 1999) for aerosolized particles.
Using particle sizes generated by the nebulizer of 0.1–10 mm (log
distribution), the estimated number of particles per each size
generated and a designated mass for each particle size, the total mass
for each particle size was calculated. The total mass was then
multiplied by a deposition fraction (percentage of particles deposited
in the respiratory tract based on size) and the fraction of total air
inhaled by each mouse {1.2%; [mouse respiration rate (163)
multiplied by tidal volume (0.00015 L)]/air flow through the system
(2 lpm)]} to give the total deposited particle mass. Using a 5% brain
homogenate, with brain material containing approximately 10% solid
material, we calculated the mass fraction of solids per particle to be
0.005 g (0.0560.10). This fraction multiplied by the total deposited
particle mass for each particle size produced the total mass of solid
material deposited. The sums from each particle size deposited mass
were then added to generate the total amount of solid inocula
deposited into each mouse.
Similar algorithms were used to estimate the total amount of solid
inoculum deposited into each intranasally inoculated mouse based on
10 ml of a 10% brain homogenate.
Western blotting. Harvested tissues were prepared at 10% (w/v) in a
16PBS/1%TritonX-100mixture.Glassbeads(2.5 mm;Biospec)were
added to each tube and samples subjected to one Fastprep (Biosalvant)
cycle for 45 s at a speed setting of 5.5, followed by a 2 min cool down at
220 uC. Samples were then centrifuged for 5 min at 2000 r.p.m.
(F241.5P Microfuge Fixed-Angle Polypropylene rotor) to remove
tissue debris and supernatants stored at 220 uCu n t i lf u r t h e ru s e .
Samples were incubated with 50 mg Proteinase K (Invitrogen) ml
21
for 30 min at 37 uC, shaking at 1000 r.p.m. Samples were then
combined with a Reducing Agent/Sample Buffer (Invitrogen) to a
(a)
(b)
Fig. 4. (a) Aerosolizing chamber with nebulizer chamber and four
plastic enclosures to accommodate anaesthetized Tg(CerPrP)
mice. (b) Top view of aerosol chamber with lid removed showing
Tg(CerPrP) mice inserted in place to provide nose-only exposure
to the chamber (arrow).
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(Invitrogen) for 2.5 h at 100 V. Proteins were then transferred to
0.22 mm PVDF membranes (Millipore) over 1.5 h at a setting
of 110 V. Membranes were blocked in a casein/TBS (Thermo
Scientific)+0.2% Tween-20 mixture for 45 min, with shaking at
room temperature. Monoclonal antibody BAR-224 (Spi-Bio) con-
jugated with HRP was used to detect the PrP
CWD (1:20000 dilution
in casein/TBS+0.2% Tween-20). Membranes were washed three
times and developed with ECL Plus Western blotting Detection kit
(GE). Blots were viewed and photographed with a Gel Doc system
(LAS-3000; Fujifilms).
IHC. Tissues were fixed in 10% formalin for 5 days, transferred to
60% ethanol (with the exception of the nasal passages), embedded in
paraffin and sectioned at 5 mm for staining. Nasal tissues were placed
in a 10% tetra-sodium EDTA (Sigma) solution for 10 days, with a
fresh solution change occurring on the fifth day. Slides were de-
paraffined through a series of xylene/ethanol baths, treated in 89%
formic acid for 30 min, rinsed in running water for 5 min and
then subjected to a 15 min antigen-retrieval process (Pickcell
Laboratories). The Dako Autostainer was used for conventional
IHC. Briefly, slides were blocked with 3% H2O2 in methanol
(30 min), blocked with TNB buffer (30 min), incubated with a 1:250
dilution of HRP-conjugated BAR-224 in TNB (45 min), developed
with chromagen AEC (3-amino-9-ethylcarbazole; Dako) (10 min),
and counterstained with haematoxylin (5 min) and bluing reagent
(1 min). Both H&E and IHC sections were evaluated for the presence
of TSE lesions, which were characterized by neuronal loss, spongiform
change and gliosis.
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